|
WASF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.30766533554561E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64546154479694E-12 |
| Normal-vs-Stage2 |
5.973800E-04 |
| Normal-vs-Stage3 |
6.79839995409992E-09 |
| Normal-vs-Stage4 |
5.94289999988895E-07 |
| Stage1-vs-Stage2 |
1.401440E-01 |
| Stage1-vs-Stage3 |
1.308000E-01 |
| Stage1-vs-Stage4 |
1.120980E-01 |
| Stage2-vs-Stage3 |
6.128000E-01 |
| Stage2-vs-Stage4 |
7.729800E-01 |
| Stage3-vs-Stage4 |
8.158400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.59792187762287E-14 |
| Normal-vs-AfricanAmerican |
2.957900E-04 |
| Normal-vs-Asian |
5.156500E-04 |
| Caucasian-vs-AfricanAmerican |
1.784010E-01 |
| Caucasian-vs-Asian |
7.611800E-01 |
| AfricanAmerican-vs-Asian |
3.577600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.67920147073642E-11 |
| Normal-vs-Female |
2.53130849614536E-14 |
| Male-vs-Female |
8.500300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.301740E-03 |
| Normal-vs-Age(41-60Yrs) |
7.37299110653566E-13 |
| Normal-vs-Age(61-80Yrs) |
3.00810487630088E-11 |
| Normal-vs-Age(81-100Yrs) |
2.487600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.985600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.544400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.986000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.505840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.273400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.771200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.80719883502434E-11 |
| Normal-vs-Grade 2 |
1.02140518265514E-14 |
| Normal-vs-Grade 3 |
3.87299969872856E-10 |
| Normal-vs-Grade 4 |
2.994000E-04 |
| Grade 1-vs-Grade 2 |
5.236000E-02 |
| Grade 1-vs-Grade 3 |
2.039300E-03 |
| Grade 1-vs-Grade 4 |
4.814300E-04 |
| Grade 2-vs-Grade 3 |
3.024300E-02 |
| Grade 2-vs-Grade 4 |
9.601500E-03 |
| Grade 3-vs-Grade 4 |
2.182600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
4.21940000000509E-05 |
| ccA subtype-vs-ccB subtype |
1.50120005315557E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.6503465261053E-12 |
| Normal-vs-N1 |
6.161900E-02 |
| N0-vs-N1 |
7.911800E-02 |
|
|
